Facial Injectors Market Research Report - Global Forecast till 2027

Facial Injectors Market Information By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – Global Forecasts till 2027

ID: MRFR/HC/5433-CR | December 2018 | Region: Global | 122 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview


The other name for facial injectors is the dermal fillers commonly used for facial rejuvenation with the help of products made from bio-engineering. With the increase in age, the collagen level in the skin starts decreasing which leads to loss of skin elasticity and loss of subcutaneous fat through which smile lines and wrinkle lines start to appear on the face as the skin is pulled towards facial working muscles. All these issues can easily be solved by using facial injectors market by using dermal fillers or facial injectors as it helps in treating the sign of aging and for adding extra glow.


The facial injectors market in the global market is expected to grow at a high CAGR of 11.12% during the forecasted period from 2016 to 2023 and to reach the market value of USD 14571.47 million by the end of the forecasted period.


COVID 19 Analysis


The global pandemic of COVID 19 has affected the facial injectors market in the global market. It has affected the health front and financial front in all the businesses that had pushed the economies into forced recession. Due to the outbreak of COVID 19 many hospitals, clinics, and other medical facilities were quite occupied in treating the patients of COVID 19 and hence leads to the downfall of revenues of the facial injectors market in the global market. Also during the lockdown situation, the facial injector market has faced a steep downfall in their profits during the forecasted period.


The facial injectors market in the global market is expected to recover from this situation of the global pandemic at the end of the first quarter and beginning of the second quarter in the coming year during the forecasted period.


Market Dynamics


Drivers


Owing to the increasing craze for self-maintenance and beauty treatments has driven the facial injectors market in the global market to great extent. The rise in the adoption of soft tissue fillers in aesthetic medicine helps in boosting the growth of the facial injectors market in the global market during the forecasted period. The increasing awareness regarding aesthetic medicine also boosts the growth of the facial injectors market.


Opportunities


The increasing demand for facial injectors market. Most of the population in the American region, Asia-Pacific region, Europe region is of mid-age or elderly population. For retaining the elasticity of the skin many people use these facial injectors and hence gives growth opportunities for the facial injectors market in the global market. Also, the rising awareness and acceptance of aesthetics treatment increase the market opportunities for the facial injectors market.


Restraints


The Facial injector market is increasing at a fast pace in the global market but some factors restrain the growth of the facial injectors market like the associated side-effects from the facial injectors and aesthetic treatment and medicines. The other factor that hampers the growth of the facial injectors market is the global market is the high cost of treatment along with high maintenance costs after the surgery or treatment. Stringent procedure regulations also hinder market growth.


Value Chain Analysis


The facial injectors market in the global market is rising at a fast pace all across the world and provides various benefits owing to its various advantages. Owing to the increase in the entertainment sector there is a huge market for facial injectors market and provides surgeries and treatment for making the skin of the actors and actresses youthful. Now not even females are looking forward to aesthetic treatment but the participation of males is also increasing day by day. It is forecasted that the facial injectors market will rise during the estimated period.


Market Segmentation


The facial injectors market in the global market has been divided based on type, application, end-user, and region.


Based on the Type


The facial injectors market in the global market has been divided based on type into two broad categories like dermal fillers/injectable implants and anti-aging/anti-wrinkle injections. The dermal filler/injectable implants are further divided into collagen fillers, synthetic fillers, and hyaluronic acid. The anti-aging/anti-wrinkle injections are further divided into botulinum toxin A and Poly-L-Lactic Acid (PLLA) Microparticles.


Based on the Application


The facial injectors market in the global market has been divided based on application into lip treatments, face-lift, and facial line correction treatment, and many others.


Based on the End-User


The facial injectors market in the global market has been divided based on end-users into hospitals, specialty clinics, Spa and beauty clinics, dermatology clinics, and cosmetic centers.


Based on the Region


The facial injectors market in the global market has been divided based on region into the Americas region, the Europe region, the Asia-Pacific region, the Middle East and Africa region, and the rest of the world.


Regional Analysis


The facial injectors market in the global market has been divided based on region into the Americas region, the Europe region, the Asia-Pacific region, the Middle East, and Africa region. The largest-share in the facial injectors market in the global market has been held by the Americas region owing to the increasing use of expenditure on cosmetic products and various procedures in many countries like the U.S. and Canada because of its huge population during the forecasted period. Also, the increasing craze of enhancing the physical appearance drives the beauty treatments and hence drives the facial injectors market in the Americas region.


Owing to the fastest-growing region the Asia-Pacific region also shows a positive growth rate for the facial injectors market. The increasing population of mid-age people and elderly population and their growing concern about beauty in the region and hence drives the facial injectors market in the Asia-Pacific region during the forecasted period from 2016 to 2023.


Competitive Landscape


The most prominent market players in the facial injectors market in the global market are the following:



  • SciVision Biotech Inc.

  • Ipsen Pharma

  • Merck KGaA

  • Sanofi Revance Therapeutics Inc.

  • Sinclair Pharma

  • Galderma S.A.

  • Medytox Inc.

  • Suneva Medical Inc.

  • Merz Pharma

  • Valeant Pharmaceuticals

  • Allergan and Integrated

  • Life Sciences Corporation


These market players in the facial injectors market in the global market uses various market strategies to capture the potential customer base all across the globe by creating innovative products, mergers and acquisitions, and different partnerships.

Recent Developments



  • In April 2019, the launch of Belotero Revive has been launched by Merz Pharma that is a combination of glycerol and HA that helps in treating fine lines by improvement in elasticity, skin firmness, and hydration. It helps in expanding the product line of the medical aesthetics business segment.

  • In September 2019, the approval from U.S. FDA for Juvederm VOLUMA XC has been announced by Allergan plc with TSK STEEiGLIDE cannula for the lifting of cheeks. It helps in correcting age-related in mid-face. This approval will help in expanding the Juvederm family of fillers demand in the global market.

  • In February 2018, Elastagen has been acquired by Allergan for incorporating Elastagen’s clinical-stage Tropoelastin platform for enhancing the facial injection portfolio in the global market.

  • In the facial injectors market, the largest share in the market in the dermal fillers in aesthetic surgeries is hyaluronic acid for increasing facial procedures in boosting the facial injectors market in the global market.

  • Advancement in technology and its application in the cosmetic industry helps in increasing the market share of the facial injectors market for boosting the growth of the cosmetic market in the global market.


Report Overview

The global facial injectors market research report consists of the following aspects:



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments



The facial injectors market research report consists of various factors that drive and restrains the market in the facial injectors market in the global market. This report also provides opportunities and the impact of COVID 19 on the global market of facial injectors market. The future growth rate is also estimated and mentioned.

Users


Investors and trade experts, Governments, associations, and industrial bodies, retailers, distributors, and wholesalers, personal care industry, venture capitalists, life science research institutes, contract research organizations, and pharmaceutical and biopharmaceutical companies, and many others.



Frequently Asked Questions (FAQ) :


Facial Injectors Market would grow up to a valuation of USD 14571.47 million by 2023.

Facial Injectors Market would register a CAGR of 11.12% during the forecast period of 2020 to 2027.

Dermatology clinics & cosmetic centers segment would lead the Facial Injectors Market.

Facial line correction segment has the upper hand in the Facial Injectors Market.

Americas market would lead the Facial Injectors Market ahead

Facial Injectors are increasingly common for their use in facial rejuvenation, treatment of scars, and other facial improvements. Increasing demand for cosmetic treatments and a growing focus on facial aesthetics has substantially increased the value of the Facial Injectors Market. Valued at USD 7740.16 Mn in 2017, various market observations suggest an expansion of the market at a CAGR of 11.12% during the review period from 2018 to 2023. At this pace of growth, the market will likely reach an estimated market value of USD 14,571.47 Mn by the end of 2023.


Facial aesthetic treatments are rising in popularity as they have become increasingly affordable and accessible in a global environment where aesthetic appearances are increasingly preferred. Aesthetic imperfections have been witnessed to be increasing in the globally rising population, and as a result, the demand for facial aesthetic treatments have also grown. Effects of pollution have been witnessed in the environment as well as in facial aesthetics. Increasing pollution has also increased skin problems such as wrinkles, uneven skin tones, dark spots, and several others, which have significantly impacted the demand for facial injectors. Moreover, technological advancements in the healthcare sector are expanding to cosmetic treatments, and leading market players are launching innovating product offerings that allow patients to achieve their desired appearance, thus boosting the demand for facial injectors. Countries such as South Korea have cosmetic improvements ingrained in their cultural perception of beauty and the growing market in the Asia Pacific is expected to propel market growth over the assessment period drastically.


The market does have a few deterrents such as complications during facial surgeries which can cause even more imperfections among other adverse effects. This is further supported by the growing black market for facial injectors and unskilled professionals who administer them, thus causing greater risks which restrain consumers from opting for such treatments. However, rising awareness regarding combination therapies and the increasing awareness regarding their benefits will lead the market toward new opportunities in the upcoming forecast period.


MRFR's report has divided the market into key segments on the basis of type, application, end-user, and region. Types of facial injectors have been segmented into dermal fillers/injectable implants, and anti-aging/anti-wrinkle injections. Between these, the dermal fillers/injectable implants segment have captured a 53% share of the global market which has put the segment in a leadership position. The dermal fillers segment has been sub-segmented into hyaluronic acid, synthetic fillers, and collagen fillers. Further sub segmentations of segments have been analyzed in the report.


Applications of facial injectors have been segmented into facial line correction treatment, face-lift, lip treatment, and others. The facial line correction treatment has been observed to have captured the largest share of the market and is on track to reach a market value of USD 6382.84 Mn by the end of 2023. Meanwhile, the facelift segment is growing at the most rapid pace and will expand at a CAGR of 11.84% during the assessment period.


End-users of facial injectors have been segmented into hospitals, dermatology clinics & cosmetic centers, and others. Among these segments, the dermatology clinics & cosmetic centers segment has reached the highest market value in 2017 and captured a share of 42.4%. Meanwhile, the hospitals segment which has the next largest share of 39.1% is slated to grow at the highest CAGR during the forecast period due to the increasing patient preference for cosmetic treatments in dermatology departments of hospitals. This shift of preference is due to the higher credibility held by hospitals.


Regional Analysis


The Americas have been established as a key region in the global market with a share of 44% and is followed by Europe and the Asia Pacific. The Americas include developed economies such as the U.S and Canada where there is high disposable income and well-developed healthcare sector which encourage the adoption of facial injectors among consumers. The region has a significant adoption of cosmetic treatments, and as such, there is a consistent demand for facial injectors.


The Asia Pacific, however, represents the fastest growing market and is slated to expand at the highest CAGR of 12.02% during the review period. Increasing demand for dermal filler techniques in the APAC region is expected to boost market growth. Moreover, in certain Asian countries such as South Korea, there is a strong focus on aesthetic beauty which has resulted in widespread adoption of facial injectors and other cosmetic treatments in the region. Rising disposable income and rapid urbanization have gradually shifted consumer preference for cosmetic treatments which is expected to assist market growth in the coming years.


Competitive Tracking


The report's analysis of the competitive landscape of the global facial injectors market includes leading market players such as Valeant Pharmaceuticals, Sinclair Pharma, Merck KGaA, Allergan, Ipsen Pharma, Sanofi, Merz Pharma, Suneva Medical Inc., Integra LifeSciences Corporation, Galderma S.A., Revance Therapeutics Inc., and SciVision Biotech Inc. These market participants use several growth strategies to achieve desirable market positions. Strategies employed include product approvals & launches, strategic acquisitions, and several others.

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 19

3.2 Scope of the Study 19

3.3 Assumptions & Limitations 19

3.3.1 Assumptions 19

3.3.2 Limitations 19

3.4 Market Structure 19

4 Research Methodology

4.1 Research Process 21

4.2 Primary Research 22

4.3 Secondary Research 23

4.4 Market Size Estimation 24

4.5 Forecast Model 24

5 Market Dynamics

5.1 Introduction 26

5.2 Drivers 27

5.2.1 Growing Demand for Facial Aesthetic Treatments 27

5.2.2 Technological Advancements 27

5.2.3 Effects of Pollution 27

5.2.4 Increasing Acceptance of Soft Tissue Fillers 27

5.2.5 1.2.5 Growing Demand for Dermal Filler Techniques from the Asian Region 27

5.3 Restraints 28

5.3.1 Complications During Surgeries 28

5.3.2 Facial Injectors Black Market 28

5.3.3 Side-Effects Associated with Facial Injectors 28

5.4 Opportunity 28

5.4.1 Rising Awareness About Combination Therapies 28

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 30

6.1.1 Bargaining Power of Suppliers 30

6.1.2 Bargaining Power of Buyers 31

6.1.3 Threat of New Entrants 31

6.1.4 Threat of Substitutes 31

6.1.5 Intense Rivalry 31

7 Facial Injectors Market, By Type

7.1 Overview 33

7.1.1 Introduction 33

7.1.2 Dermal Fillers/Injectable Implants 35

7.1.3 Anti-Aging/Anti-Wrinkle Injections 35

8 Facial Injectors Market, By Application

8.1 Overview 38

8.1.1 Introduction 38

8.1.2 Facial Line Correction Treatment 39

8.1.3 Face-Lift 40

8.1.4 Lip Treatments 40

9 Facial Injectors Market, By End-User

9.1 Overview 42

9.1.1 Introduction 42

9.1.2 Dermatology Clinics & Cosmetic Centers 43

9.1.3 Hospitals 43

10 Global Facial Injectors Market, By Region

10.1 Introduction 46

10.2 Americas 47

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.2.1 North America 50

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.2.1.1 U.S. 52

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.2.1.2 Canada 53

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.2.2 South America 55

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3 Europe 58

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.1 Western Europe 60

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.1.1 Germany 62

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.1.2 U.K 64

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.1.3 France 66

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.1.4 Italy 68

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.1.5 Spain 69

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.1.6 Rest of Western Europe 71

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.3.2 Eastern Europe 73

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.4 Asia Pacific 75

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.4.1 Japan 77

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.4.2 China 78

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.4.3 Republic of Korea 80

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.4.4 India 82

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.4.5 Australia 83

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.4.6 Rest of Asia Pacific 85

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.5 The Middle East and Africa 88

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.5.1 Middle East 90

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

10.5.2 Africa 91

Facial Injectors Market, By Type

Facial Injectors Market, By Application

Facial Injectors Market, By End-User

11 Competitive Landscape

11.1 Company Market Share Analysis 95

11.1.1 Introduction 95

12 Company Profiles

12.1 Galderma S.A. 97

12.1.1 Company Overview 97

12.1.1 Financial Overview 97

12.1.2 Products Offering 98

12.1.3 Key Developments 98

12.1.4 SWOT Analysis 98

12.1.5 Key Strategy 98

12.2 Allergan 99

12.2.1 Company Overview 99

12.2.2 Financial Overview 99

12.2.3 Products Offering 100

12.2.4 Key Developments 100

12.2.5 SWOT Analysis 100

12.2.6 Key Strategy 100

12.3 Merz Pharma 101

12.3.1 Company Overview 101

12.3.2 Financial Overview 101

12.3.3 Products Offering 102

12.3.4 Key Developments 102

12.3.5 SWOT Analysis 102

12.3.6 Key Strategy 102

12.4 Valeant Pharmaceuticals 103

12.4.1 Company Overview 103

12.4.2 Financial Overview 103

12.4.3 Products Offering 104

12.4.4 Key Developments 104

12.4.5 SWOT Analysis 104

12.4.6 Key Strategy 104

12.5 Integra LifeSciences Corporation 105

12.5.1 Company Overview 105

12.5.2 Financial Overview 105

12.5.3 Products Offering 106

12.5.4 Key Developments 106

12.5.5 SWOT Analysis 106

12.5.6 Key Strategy 106

12.6 Sanofi 107

12.6.1 Company Overview 107

12.6.2 Financial Overview 107

12.6.3 Products Offering 108

12.6.4 Key Developments 108

12.6.5 SWOT Analysis 108

12.6.6 Key Strategy 108

12.7 Sinclair Pharma 109

12.7.1 Company Overview 109

12.7.2 Financial Overview 109

12.7.3 Products Offering 110

12.7.4 Key Developments 110

12.7.5 SWOT Analysis 110

12.7.6 Key Strategy 110

12.8 Suneva Medical, Inc. 111

12.8.1 Company Overview 111

12.8.2 Financial Overview 111

12.8.3 Products Offering 111

12.8.4 Key Developments 111

12.8.5 SWOT Analysis 111

12.8.6 Key Strategy 111

12.9 SciVision Biotech Inc 112

12.9.1 Company Overview 112

12.9.2 Financial Overview 112

12.9.3 Products Offering 112

12.9.4 Key Developments 112

12.9.5 SWOT Analysis 112

12.9.6 Key Strategy 112

12.10 Revance Therapeutics, Inc. 113

12.10.1 Company Overview 113

12.10.2 Financial Overview 113

12.10.3 Products Offering 113

12.10.4 Key Developments 113

12.10.5 SWOT Analysis 114

12.10.6 Key Strategy 114

12.11 Merck KGaA 115

12.11.1 Company Overview 115

12.11.2 Financial Overview 115

12.11.3 Products Offering 116

12.11.4 Key Developments 116

12.11.5 SWOT Analysis 116

12.11.6 Key Strategy 116

12.12 Ipsen Pharma 117

12.12.1 Company Overview 117

12.12.2 Financial Overview 117

12.12.3 Products Offering 118

12.12.4 Key Developments 118

12.12.5 SWOT Analysis 118

12.12.6 Key Strategy 118

13 Appendix

13.1 Discussion Blue Print 120

14 List of Tables

TABLE 1 MARKET SYNOPSIS 17

TABLE 2 PRIMARY INTERVIEWS 21

TABLE 3 GLOBAL FACIAL INJECTORS MARKET BY TYPE, 2020-2027 (USD MILLION) 34

TABLE 4 GLOBAL FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 34

TABLE 5 GLOBAL FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 34

TABLE 6 GLOBAL FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 34

TABLE 7 GLOBAL FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS, BY REGION, 2020-2027 (USD MILLION) 35

TABLE 8 GLOBAL FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS, BY REGION, 2020-2027 (USD MILLION) 36

TABLE 9 GLOBAL FACIAL INJECTORS MARKET BY APPLICATION, 2020-2027 (USD MILLION) 39

TABLE 10 GLOBAL FACIAL INJECTORS MARKET FOR FACIAL LINE CORRECTION TREATMENT, BY REGION, 2020-2027 (USD MILLION) 39

TABLE 11 GLOBAL FACIAL INJECTORS MARKET FOR FACE-LIFT, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 12 GLOBAL FACIAL INJECTORS MARKET FOR LIP TREATMENTS, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 13 GLOBAL FACIAL INJECTORS MARKET BY END-USER, 2020-2027 (USD MILLION) 43

TABLE 14 GLOBAL FACIAL INJECTORS MARKET FOR DERMATOLOGY CLINICS & COSMETIC CENTERS, BY REGION, 2020-2027 (USD MILLION) 43

TABLE 15 GLOBAL FACIAL INJECTORS MARKET FOR HOSPITALS, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 16 GLOBAL FACIAL INJECTORS MARKET, BY REGION, 2020-2027 (USD MILLION) 46

TABLE 17 AMERICAS: FACIAL INJECTORS MARKET, BY REGION, 2020-2027 (USD MILLION) 48

TABLE 18 AMERICAS FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 48

TABLE 19 AMERICAS FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 48

TABLE 20 AMERICAS FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 48

TABLE 21 AMERICAS FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 49

TABLE 22 AMERICAS FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 49

TABLE 23 AMERICAS FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 49

TABLE 24 NORTH AMERICA FACIAL INJECTORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 50

TABLE 25 NORTH AMERICA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 50

TABLE 26 NORTH AMERICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 50

TABLE 27 NORTH AMERICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 50

TABLE 28 NORTH AMERICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 51

TABLE 29 NORTH AMERICA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 51

TABLE 30 NORTH AMERICA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 51

TABLE 31 U.S. FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 52

TABLE 32 U.S. FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 52

TABLE 33 U.S. FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 52

TABLE 34 U.S. FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 52

TABLE 35 U.S. FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 53

TABLE 36 U.S. FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 53

TABLE 37 CANADA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 53

TABLE 38 CANADA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 54

TABLE 39 CANADA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 54

TABLE 40 CANADA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 54

TABLE 41 CANADA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 55

TABLE 42 CANADA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 55

TABLE 43 SOUTH AMERICA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 55

TABLE 44 SOUTH AMERICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 56

TABLE 45 SOUTH AMERICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 56

TABLE 46 SOUTH AMERICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 56

TABLE 47 SOUTH AMERICA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 57

TABLE 48 SOUTH AMERICA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 57

TABLE 49 EUROPE: FACIAL INJECTORS MARKET, BY REGION, 2020-2027 (USD MILLION) 58

TABLE 50 EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 58

TABLE 51 EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 52 EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 53 EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 54 EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 59

TABLE 55 EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 60

TABLE 56 WESTERN EUROPE: FACIAL INJECTORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 60

TABLE 57 WESTERN EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 58 WESTERN EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 61

TABLE 59 WESTERN EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 61

TABLE 60 WESTERN EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 61

TABLE 61 WESTERN EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 62

TABLE 62 WESTERN EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 62

TABLE 63 GERMANY FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 64 GERMANY FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 65 GERMANY FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 66 GERMANY FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 67 GERMANY FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 64

TABLE 68 GERMANY FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 64

TABLE 69 U.K FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 64

TABLE 70 U.K FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 71 U.K FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 72 U.K FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 73 U.K FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 65

TABLE 74 U.K FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 66

TABLE 75 FRANCE FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 76 FRANCE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 77 FRANCE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 78 FRANCE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 67

TABLE 79 FRANCE FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 67

TABLE 80 FRANCE FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 67

TABLE 81 ITALY FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 82 ITALY FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 83 ITALY FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 84 ITALY FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 85 ITALY FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 69

TABLE 86 ITALY FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 69

TABLE 87 SPAIN FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 69

TABLE 88 SPAIN FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 89 SPAIN FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 90 SPAIN FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 91 SPAIN FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 70

TABLE 92 SPAIN FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 71

TABLE 93 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 94 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 95 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 96 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 72

TABLE 97 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 72

TABLE 98 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 72

TABLE 99 EASTERN EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 100 EASTERN EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 101 EASTERN EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 102 EASTERN EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 103 EASTERN EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 74

TABLE 104 EASTERN EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 74

TABLE 105 ASIA PACIFIC FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 75

TABLE 106 ASIA PACIFIC FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 75

TABLE 107 ASIA PACIFIC FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 76

TABLE 108 ASIA PACIFIC FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 76

TABLE 109 ASIA PACIFIC FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76

TABLE 110 ASIA PACIFIC FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 76

TABLE 111 JAPAN FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 112 JAPAN FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 113 JAPAN FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 114 JAPAN FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 115 JAPAN FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78

TABLE 116 JAPAN FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 78

TABLE 117 CHINA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 78

TABLE 118 CHINA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 79

TABLE 119 CHINA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 79

TABLE 120 CHINA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 79

TABLE 121 CHINA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 79

TABLE 122 CHINA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 80

TABLE 123 REPUBLIC OF KOREA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 124 REPUBLIC OF KOREA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 125 REPUBLIC OF KOREA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 126 REPUBLIC OF KOREA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 81

TABLE 127 REPUBLIC OF KOREA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 81

TABLE 128 REPUBLIC OF KOREA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 81

TABLE 129 INDIA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 130 INDIA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 131 INDIA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 132 INDIA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 133 INDIA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 83

TABLE 134 INDIA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 83

TABLE 135 AUSTRALIA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 136 AUSTRALIA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 84

TABLE 137 AUSTRALIA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 84

TABLE 138 AUSTRALIA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 84

TABLE 139 AUSTRALIA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 85

TABLE 140 AUSTRALIA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 85

TABLE 141 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 85

TABLE 142 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 143 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 144 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 145 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 87

TABLE 146 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 87

TABLE 147 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 88

TABLE 148 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 88

TABLE 149 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 89

TABLE 150 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 89

TABLE 151 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 89

TABLE 152 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 89

TABLE 153 MIDDLE EAST FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 154 MIDDLE EAST FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 155 MIDDLE EAST FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 156 MIDDLE EAST FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 157 MIDDLE EAST FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 91

TABLE 158 MIDDLE EAST FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 91

TABLE 159 AFRICA FACIAL INJECTORS MARKET, BY TYPE, 2020-2027 (USD MILLION) 91

TABLE 160 AFRICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2020-2027 (USD MILLION) 92

TABLE 161 AFRICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2020-2027 (USD MILLION) 92

TABLE 162 AFRICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2020-2027 (USD MILLION) 92

TABLE 163 AFRICA FACIAL INJECTORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92

TABLE 164 AFRICA FACIAL INJECTORS MARKET, BY END-USER, 2020-2027 (USD MILLION) 93


15 List of Figures

FIGURE 1 GLOBAL FACIAL INJECTORS MARKET: MARKET STRUCTURE 19

FIGURE 2 RESEARCH PROCESS 21

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 24

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FACIAL INJECTORS MARKET 26

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL FACIAL INJECTORS MARKET 30

FIGURE 6 GLOBAL FACIAL INJECTORS MARKET, BY TYPE, 2020 (% SHARE) 33

FIGURE 7 GLOBAL FACIAL INJECTORS MARKET, BY TYPE, 2020 & 2027 33

FIGURE 8 GLOBAL FACIAL INJECTORS MARKET, BY APPLICATION, 2020 (% SHARE) 38

FIGURE 9 GLOBAL FACIAL INJECTORS MARKET, BY APPLICATION, 2020 & 2027 38

FIGURE 10 GLOBAL FACIAL INJECTORS MARKET, BY END-USER, 2020 (% SHARE) 42

FIGURE 11 GLOBAL FACIAL INJECTORS MARKET, BY END-USER, 2020 & 2027 42

FIGURE 12 GLOBAL FACIAL INJECTORS MARKET, BY REGION, 2020 & 2027(USD MILLION) 46

FIGURE 13 GLOBAL FACIAL INJECTORS MARKET, BY REGION, 2020 (% SHARE) 47

FIGURE 14 AMERICAS: FACIAL INJECTORS MARKET SHARE, BY REGION, 2020 (% SHARE) 47

FIGURE 15 EUROPE: FACIAL INJECTORS MARKET SHARE, BY REGION, 2020 (% SHARE) 58

FIGURE 16 ASIA PACIFIC: FACIAL INJECTORS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 75

FIGURE 17 THE MIDDLE EAST AND AFRICA: FACIAL INJECTORS MARKET SHARE, BY REGION, 2020 (% SHARE) 88

FIGURE 18 GLOBAL FACIAL INJECTORS MARKET, MARKET SHARE ANALYSIS 2020 (% SHARE) 95



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Numerous players are operating in the global facial injectors market. Some of the big players have captured a significant share in the global market, taking advantage of their strong position and presence in the number of countries and regions across the world.


The top players in the global facial injectors market are Allergan, Ipsen Pharma, Merz Pharma, Galderma S.A., and Sinclair Pharma. Allergan accounted for 25.5% of the global facial injectors market share in 2017. It is one of the largest and fastest growing market players in the aesthetics and cosmetic procedures segment.


Ipsen Pharma accounted for the second-largest market share of 20.0% in 2017. It operates in endocrinology, oncology, neurology, cognitive disorders, gastroenterology, and rheumatology areas. The company has a strong research and development unit which offers innovative products.


Merz Pharma operates in segments, namely, neurology, over the counter (OTC) medicine, dietary supplements, and skincare products. The company accounted for 18.5% of the total market share in 2017.


Galderma S.A. holds the fourth largest position in the global facial injectors market with a market share of 17.0%. It is one of the largest dermatology medicine manufacturers in the world and it has strategic partnerships with many strong brands.


Sinclair Pharma is into manufacturing and marketing of pharmaceuticals, aesthetics, and cosmetic products. The company has a strong presence in the major aesthetics market. It holds the fifth largest position in the global facial injectors market with a market share of 5.8%.


Intended Audience



  • Dermal fillers manufacturers & suppliers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Academic institutes and universities